Risk of prostate cancer in men with HIV/AIDS: a systematic review and meta-analysis

[1]  Esperanza Cañas-Ruano,et al.  Incidencia de neoplasias en una cohorte española de pacientes con infección por el virus de la inmunodeficiencia humana , 2020 .

[2]  Ni Li,et al.  Risk of prostate cancer in men with HIV/AIDS: a systematic review and meta-analysis , 2020, Prostate Cancer and Prostatic Diseases.

[3]  D. Trisciuoglio,et al.  Reverse transcriptase inhibitors promote the remodeling of nuclear architecture and induce autophagy in prostate cancer cells. , 2020, Cancer letters.

[4]  E. Cañas-Ruano,et al.  Incidence of malignancy in a Spanish cohort of patients infected by the human immunodeficiency virus. , 2020 .

[5]  J. Johnston,et al.  Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. , 2019, The Lancet. Infectious diseases.

[6]  J. García,et al.  Risk of cancer in HIV-infected patients in Spain, 2004-2015. The CoRIS cohort study. , 2019, Enfermedades infecciosas y microbiologia clinica.

[7]  M. Vivancos,et al.  Risk of cancer in HIV-infected patients in Spain, 2004–2015. The CoRIS cohort study , 2019, Enfermedades infecciosas y microbiologia clinica (English ed.).

[8]  E. Engels,et al.  HIV Infection, Cancer Treatment Regimens, and Cancer Outcomes Among Elderly Adults in the United States. , 2019, JAMA oncology.

[9]  M. Egger,et al.  The burden of cancers associated with HIV in the South African public health sector, 2004–2014: a record linkage study , 2019, Infectious Agents and Cancer.

[10]  E. Engels,et al.  Disparities and Determinants of Cancer Treatment in Elderly Americans Living With Human Immunodeficiency Virus/AIDS , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  E. Vittinghoff,et al.  Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study. , 2018, The lancet. HIV.

[12]  M. Schymura,et al.  Risk of Breast, Prostate, and Colorectal Cancer Diagnoses Among HIV-Infected Individuals in the United States , 2018, Journal of the National Cancer Institute.

[13]  C. Heumann,et al.  Risk for cancer among people living with AIDS, 1997–2012: the São Paulo AIDS–cancer linkage study , 2018, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[14]  S. Franceschi,et al.  A case–control study of HIV infection and cancer in the era of antiretroviral therapy in Rwanda , 2018, International journal of cancer.

[15]  N. Hessol,et al.  Changing temporal trends in non-AIDS cancer mortality among people diagnosed with AIDS: San Francisco, California, 1996-2013. , 2018, Cancer epidemiology.

[16]  J. Orem,et al.  HIV Status and Associated Clinical Characteristics Among Adult Patients With Cancer at the Uganda Cancer Institute , 2017, Journal of global oncology.

[17]  E. Engels,et al.  Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. , 2017, The lancet. HIV.

[18]  H. Uno,et al.  Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study , 2017, Cancer Causes & Control.

[19]  J. Palefsky,et al.  Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy , 2016, Journal of cancer epidemiology.

[20]  R. Paranjape,et al.  HIV and cancer registry linkage identifies a substantial burden of cancers in persons with HIV in India , 2016, Medicine.

[21]  A. Justice,et al.  Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997–2012 , 2016, AIDS.

[22]  H. Katki,et al.  Cancer risk among the HIV-infected elderly in the United States , 2016, AIDS.

[23]  E. Simard,et al.  Retrospective cohort study of cancer incidence and mortality by HIV status in a Georgia, USA, prisoner cohort during the HAART era , 2016, BMJ Open.

[24]  Jaeyoung Kim,et al.  Living near nuclear power plants and thyroid cancer risk: A systematic review and meta-analysis. , 2016, Environment international.

[25]  S. Dalton,et al.  Association Between Educational Level and Risk of Cancer in HIV-infected Individuals and the Background Population: Population-based Cohort Study 1995-2011. , 2015, The Journal of infectious diseases.

[26]  Richard D Moore,et al.  Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. , 2015, Annals of internal medicine.

[27]  E. Engels,et al.  Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  R. Pfeiffer,et al.  Excess cancers among HIV-infected people in the United States. , 2015, Journal of the National Cancer Institute.

[29]  F. Donato,et al.  Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study , 2015, BMC Public Health.

[30]  T. Sterling,et al.  HIV and cancer: a comparative retrospective study of Brazilian and U.S. clinical cohorts , 2015, Infectious Agents and Cancer.

[31]  F. Ichas,et al.  A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer. , 2014, The oncologist.

[32]  S. K. Van Den Eeden,et al.  Prostate Cancer Incidence and Prostate-Specific Antigen Testing Among HIV-Positive and HIV-Negative Men , 2014, Journal of acquired immune deficiency syndromes.

[33]  G. Copeland,et al.  Cancer treatment disparities in HIV-infected individuals in the United States. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  S. Bojesen,et al.  Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV , 2014, AIDS.

[35]  Kholoud Porter,et al.  Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy , 2014, AIDS.

[36]  M. Law,et al.  Cancer Incidence in a Nationwide HIV/AIDS Patient Cohort in Taiwan in 1998–2009 , 2014, Journal of acquired immune deficiency syndromes.

[37]  C. Adebamowo,et al.  Cancer burden among HIV-positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study , 2014, Infectious Agents and Cancer.

[38]  Yair Lotan,et al.  Systematic review of complications of prostate biopsy. , 2013, European urology.

[39]  Mohammad Hassan Murad,et al.  Early detection of prostate cancer: AUA Guideline. , 2013, The Journal of urology.

[40]  M. Magoni,et al.  Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era. , 2013, AIDS research and human retroviruses.

[41]  S. Antinori,et al.  Trends and Predictors of Non–AIDS-Defining Cancers in Men and Women With HIV Infection: A Single-Institution Retrospective Study Before and After the Introduction of HAART , 2013, Journal of acquired immune deficiency syndromes.

[42]  D. Klein,et al.  Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons , 2012, AIDS.

[43]  D. Klein,et al.  HIV Infection, Immunodeficiency, Viral Replication, and the Risk of Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[44]  J. Atashili,et al.  Prevalence, severity, and duration of thrombocytopenia among HIV patients in the era of highly active antiretroviral therapy , 2011 .

[45]  A. Israni,et al.  Spectrum of cancer risk among US solid organ transplant recipients. , 2011, JAMA.

[46]  I. Mills,et al.  The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis , 2011, The EMBO journal.

[47]  A. Molinari,et al.  The Reverse Transcription Inhibitor Abacavir Shows Anticancer Activity in Prostate Cancer Cell Lines , 2010, PloS one.

[48]  R. Pfeiffer,et al.  Age at Cancer Diagnosis Among Persons With AIDS in the United States , 2010, Annals of Internal Medicine.

[49]  Richard D Moore,et al.  Reduced Risk of Prostate Cancer in U.S. Men with AIDS , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[50]  E. Simard,et al.  Spectrum of cancer risk late after AIDS onset in the United States. , 2010, Archives of internal medicine.

[51]  S. Franceschi,et al.  Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study , 2010, British Journal of Cancer.

[52]  S. Cole,et al.  A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected Individuals , 2009, Journal of acquired immune deficiency syndromes.

[53]  D. Klein,et al.  HIV infection and the risk of cancers with and without a known infectious cause , 2009, AIDS.

[54]  J. Kaldor,et al.  Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy , 2009, AIDS.

[55]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[56]  B. Gazzard,et al.  Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  S. Franceschi,et al.  Pattern of cancer risk in persons with AIDS in Italy in the HAART era , 2009, British Journal of Cancer.

[58]  John A. Hall,et al.  Association between HIV status and Positive Prostate Biopsy in a Study of U.S. Veterans , 2009, TheScientificWorldJournal.

[59]  Nikolaos A Patsopoulos,et al.  Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. , 2008, International journal of epidemiology.

[60]  P. Sullivan,et al.  Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. , 2008, Annals of internal medicine.

[61]  Richard D Moore,et al.  Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals , 2008, AIDS.

[62]  M. Falster,et al.  Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis , 2007, The Lancet.

[63]  H. Furrer,et al.  Hypogonadism in HIV-1-Infected Men is common and does not resolve during antiretroviral therapy , 2007, Antiviral therapy.

[64]  E. Wolf,et al.  Hohe Inzidenz nicht AIDS-definierender Neoplasien bei HIV-infizierten Patienten in Deutschland , 2006 .

[65]  R. Baggaley,et al.  Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis , 2006, AIDS.

[66]  D. Parkin,et al.  Spectrum of cancers among HIV‐infected persons in Africa: The Uganda AIDS‐Cancer Registry Match Study , 2006, International journal of cancer.

[67]  M. Wallace,et al.  A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: diagnosis, pathogenesis, and management. , 2005, AIDS patient care and STDs.

[68]  Y. Ohtsuki,et al.  HIV‐1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signaling , 2005, Cancer science.

[69]  H. Møller,et al.  The risk of cancer in HIV-infected people in southeast England: a cohort study , 2004, British Journal of Cancer.

[70]  R. Biggar,et al.  Cancer Risk in Elderly Persons With HIV/AIDS , 2004, Journal of acquired immune deficiency syndromes.

[71]  D. Costagliola,et al.  Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[72]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[73]  S. Franceschi,et al.  Risk of cancer in persons with AIDS in Italy, 1985–1998 , 2003, British Journal of Cancer.

[74]  Frank Pajonk,et al.  The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells. , 2002, Cancer research.

[75]  M. Schymura,et al.  Cancer incidence in New York State acquired immunodeficiency syndrome patients. , 2001, American journal of epidemiology.

[76]  S. Franceschi,et al.  [Methodological issues and first results of a record linkage between AIDS and Cancer Registries in Italy]. , 2000, Epidemiologia e prevenzione.

[77]  Hiv Survival,et al.  Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis , 2000, The Lancet.

[78]  S. Franceschi,et al.  Cancer risk among men with, or at risk of, HIV infection in southern Europe , 2000, AIDS.

[79]  V. Beral,et al.  The spectrum of HIV‐1 related cancers in South Africa , 2000, International journal of cancer.

[80]  A. Dobs,et al.  Serum hormones in men with human immunodeficiency virus-associated wasting. , 1996, The Journal of clinical endocrinology and metabolism.

[81]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[82]  J. del Romero,et al.  Risk of cancer in HIV-infected patients in Spain, 2004-2015. The CoRIS cohort study. , 2019, Enfermedades infecciosas y microbiologia clinica.

[83]  K. Rothman,et al.  Epidemiologic Analysis with a Programmable Calculator , 1982 .